Shilpa Medicare Limited has intimated the stock exchanges (BSE and NSE) about a scheduled meeting of its Board of Directors. The meeting is set to be held on Wednesday, 5th August 2026. The primary agenda of this board meeting is to consider and approve the company's unaudited financial results for the quarter ended 30th June 2026 (Q1 FY27).
In compliance with the company's Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the company's securities has been closed effective from 1st July 2026. The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended 30th June 2026.
A copy of this intimation has been made available on the company's website at: https://www.vbshilpa.com/stock-exchange-intimations.php